申请人:Celtice Catalysts Limited, Nova UCD
公开号:US08067642B2
公开(公告)日:2011-11-29
The present invention provides P-chiral compounds of general formulae (II) and (III): in formula (II) at least one of R21, R25, R26 and R30 is independently selected from CM alkyl, CF3, C1-4 alkoxy, phenyl and benzyloxy and the remaining substituents selected from R21, R25, R26 and R30 are hydrogen; at least one of R22, R24, R27 and R29 are independently selected from C1-14 alkyl, CF3, C1-14 alkoxy, phenyl and benzyloxy and the remaining substituents selected, from R22, R24, R27 and R29 are hydrogen; and R23 and R28 are independently selected from hydrogen, CM alkyl, CF3, C1-14 alkoxy, phenyl and benzyloxy; in formula (III) at least one of R21, R25, R26 and R30 is independently selected from phenyl and benzyloxy and the remaining substituents selected from R21, R25, R−26 and R30 are hydrogen; and R22, R−23 R24, R27, R28 and R29 are independently selected from hydrogen, C1-14 alkyl, CF3, C1-14 alkoxy, phenyl and benzyloxy.
本发明提供了一般式(II)和(III)的P-手性化合物:在式(II)中,R21、R25、R26和R30中至少一个独立地选自CM烷基、CF3、C1-4烷氧基、苯基和苄氧基,其余取代基选自R21、R25、R26和R30为氢;R22、R24、R27和R29中至少一个独立地选自C1-14烷基、CF3、C1-14烷氧基、苯基和苄氧基,其余取代基选自R22、R24、R27和R29为氢;R23和R28独立地选自氢、CM烷基、CF3、C1-14烷氧基、苯基和苄氧基;在式(III)中,R21、R25、R26和R30中至少一个独立地选自苯基和苄氧基,其余取代基选自R21、R25、R-26和R30为氢;R22、R-23、R24、R27、R28和R29独立地选自氢、C1-14烷基、CF3、C1-14烷氧基、苯基和苄氧基。